John N. Kapoor, Director, 10% Owner at Insys Therapeutics, Inc. (INSY), bought 5,000 shares at $26.53 ($131K) on 2014-06-16, disclosed to the SEC on 2014-06-18.
Open-market purchase of $131k INSY by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.85 | 3,000 | $78K | 59.4% |
| 2 | $26.53 | 2,000 | $53K | 40.6% |
| Total | $26.12 avg | 5,000 | $131K | 100% |
| Filing → |
| AKRX | BUY | 2015-03-10 | $841K | — | Filing → |
| AKRX | SELL | 2014-12-12 | $2.1M | — | Filing → |
| AKRX | SELL | 2014-08-27 | $1.9M | — | Filing → |